Skip to main content
. 2009 Jun 24;16(8):1236–1246. doi: 10.1128/CVI.00431-08

FIG. 5.

FIG. 5.

GMCs (mIU/ml) at each blood sampling time point in study A (elderly patients), study E (adolescents), and study F (infants) for the anti-HBs in-house assay versus reference assays. PI to PIV repesent postdose months 1 to 4, respectively, and m1, m2, etc., represent study months 1, 2, etc.